Biotech Startups

1 investor

Develops lateral flow assay (LFA) diagnostic test kits for urine-based and blood-based testing, offering a range of products across various test panels. The kits include the test kit, manual, and desiccant.

1 investor

QSM Diagnostics develops bacterial infection testing for pets using Quorum Sensing Technology, offered as mail-in kits and in-clinic instruments. It serves veterinary clinics and pet owners with rapid diagnostics for issues such as ear infections, aiming to speed treatment decisions and reduce antimicrobial resistance.

1 investor

QTSense develops quantum sensors operating at the nanoscale to detect subtle biological signals for research and diagnostic applications. The company serves academic and pharmaceutical researchers seeking earlier disease detection and improved treatment development.

1 investor

Qtas develops a quantum-sensor-based microscopy platform, described as the world's smallest MRI, that detects, sorts, and recovers intact individual rare cells (such as circulating tumor cells and rare immune cells) directly from unprocessed biological samples like whole blood or spinal fluid. The platform serves pharma, biotech, and liquid biopsy partners as an upstream tool feeding downstream molecular, genomic, proteomic, and single-cell analysis.

1 investor

Quadriga BioSciences is an oncology startup developing targeted small molecule chemotherapeutics for cancer treatment, with a focus on central nervous system malignancies and immune-mediated disorders. The company works in partnership with leading academic oncology researchers and clinicians.

1 investor

Qualterra provides molecular plant testing services for horticultural and agricultural operations, including virus screening, variety verification, and genomic analysis. The company serves growers, nurseries, and breeders seeking early pathogen detection, plant identity confirmation, and crop protection through advanced DNA/RNA testing technologies.

1 investor

QuantaMatrix is an in-vitro diagnostics company that develops rapid antimicrobial susceptibility tests to reduce treatment time for sepsis and tuberculosis. The company's core offering addresses hospitals and clinicians seeking to optimize antimicrobial therapy and combat antimicrobial resistance.

1 investor

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.

1 investor

Quercis Pharma is a pharmaceutical company focused on drug discovery and development with an emphasis on making medicines accessible, affordable, and equitable globally. The company prioritizes patient outcomes and sustainable delivery of treatments across all communities.

1 investor

QUIITOS develops bio-inputs based on beneficial microorganisms for use in agriculture, food production, and floriculture industries. The company serves farmers and food producers with sustainable, nature-based solutions to enhance productivity and environmental health.

1 investor

Quilt is a data management and governance platform that organizes scientific data stored in AWS S3 into versioned, governed packages for research teams. The platform enables scientists to search, browse, version control, and apply governance to laboratory data while maintaining it within their own cloud infrastructure.

1 investor

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

1 investor

QuitoFoods is an agritech company working on regenerative agriculture and plant genome editing ("Regenetic Engineering") to develop gene-adaptive crops, closed-loop nutrient systems, and AI-assisted distributed growing infrastructure. It connects small farming cooperatives in Latin America with synthetic biologists, climate engineers, and biotech labs, with operations spanning Ecuador and California.

1 investor

Qumir Nano develops crop protection and plant health products by combining microbial metabolites with nanostructured delivery systems to improve crop performance while reducing chemical inputs. Its technology targets agricultural challenges such as fungal disease, soil degradation and climate variability for farmers.

1 investor

Quodria develops treatments for patients with chronic skin diseases through innovative pharmaceutical solutions. The company brings together biotech experts with experience in drug discovery and late-stage clinical development.

1 investor

Quoin Pharmaceuticals is a pharmaceutical company developing therapeutic products for rare diseases, with a lead candidate, QRX003, in clinical trials for Netherton Syndrome. It plans commercial operations in the US, Western Europe, and Japan, supported by international marketing and distribution partnerships across 61 countries.

1 investor

Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.

1 investor

R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.

1 investor

Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.

1 investor

Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.

1 investor

Radicle Science runs clinical trials and evidence-generation studies for wellness products—including supplements, food and beverage, and pet wellness—using large, demographically diverse datasets, DTC tests, wearables, and AI analysis. It offers a "Proof-as-a-Service" platform for brands seeking science-backed claims across health areas via RCTs, open-label, and in-home use tests.

1 investor

Radius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).

1 investor

Radix Labs develops software systems that manage operations and workflows in biological research laboratories.

1 investor